This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Pablo Denes, MD; Eugene Uretz, MS; Marilyn D. Ezri, MD; Joseph Borbola, MD

Arch Intern Med. 1988;148(9):1922-1928.

Abstract
• Unexplained syncope is a common medical problem. Intracardiac electrophysiologic studies (EPS) have been used to uncover the underlying arrhythmic mechanisms. Electrophysiologic studies are especially helpful in the management of patients with inducible tachyarrhythmias, but is of limited usefulness in those with normal EPS findings. We investigated whether clinical and noninvasive laboratory variables can predict the results of EPS in 89 patients with unexplained syncope. The prevalence of inducible ventricular tachycardia (VT) was 15%; supraventricular tachycardia, 15%; bradyarrhythmias, 41%; and normal EPS, 29%. We used multivariate discriminant function analysis to predict the results of EPS. The variables selected for identification of patients with inducible VT by this analysis include New York Heart Association (NYHA) functional class, gender, digitalis use, nonsustained VT, and atrial fibrillation. Based on our statistical model, performing EPS on 45% of the patients with unexplained syncope would result in a 90% sensitivity in detecting patients with inducible VT. The variables selected for identification of patients with normal EPS findings include: New York Heart Association functional class, heart disease, digitalis use, and intraventricular conduction. Based on this model, it would require that all but 12% of patients with unexplained syncope be studied to achieve a 90% predictive accuracy for identification of patients with normal EPS. During follow-up, recurrence rates for the different EPS categories did not differ significantly. The five-year cumulative survival among the EPS groups were as follows: VT, 37%±28%; SVT, 90%±9%; bradyarrhythmias, 71%±10%; and normal EPS, 96%±4%. Survival of the VT group differed significantly from that of the normal group. In patients with unexplained syncope, EPS findings can be predicted from clinical and noninvasive laboratory data. Mortality during follow-up relates to EPS findings.

(Arch Intern Med 1988;148:1922-1928)

Author Affiliations
From the Section of Cardiology, Department of Medicine, Rush-Presbyterian—St Luke's Medical Center, Chicago.

Footnotes
Accepted for publication May 3, 1988.

Reprint requests to Section of Cardiology, Rush-Presbyterian—St Luke's Medical Center, 1750 W Harrison St, Chicago, IL 60612 (Dr Denes).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Developed in Collaboration With the European Heart et al.
J Am Coll Cardiol 2006;48:e247-e346.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:746-837.
FULL TEXT  

Collapse query cause: the management of adult syncope in the emergency department.
Reed and Gray
Emerg. Med. J. 2006;23:589-594.
ABSTRACT | FULL TEXT  

Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
Pezawas et al.
Europace 2003;5:305-312.
ABSTRACT | FULL TEXT  

Risk stratification of patients with syncope in an accident and emergency department
Crane
Emerg. Med. J. 2002;19:23-27.
ABSTRACT | FULL TEXT  

Randomized Assessment of Syncope Trial : Conventional Diagnostic Testing Versus a Prolonged Monitoring Strategy
Krahn et al.
Circulation 2001;104:46-51.
ABSTRACT | FULL TEXT  

Variations in diagnostic yield of head-up tilt test and electrophysiology in groups of patients with syncope of unknown origin
Sagrista-Sauleda et al.
Eur Heart J 2001;22:857-865.
ABSTRACT  

Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: A comparison with patients known to have sustained ventricular tachycardia
Andrews et al.
J Am Coll Cardiol 1999;34:2023-2030.
ABSTRACT | FULL TEXT  

Implantable loop recorder: evaluation of unexplained syncope
Kenny and Krahn
Heart 1999;81:431-433.
FULL TEXT  

The Etiology of Syncope in Patients With Negative Tilt Table<$DOWNLINK> and Electrophysiological Testing
Krahn et al.
Circulation 1995;92:1819-1824.
ABSTRACT | FULL TEXT  

Electrophysiological Testing : The Final Court of Appeal for Diagnosis of Syncope?
Klein et al.
Circulation 1995;92:1332-1335.
FULL TEXT  

Evaluation and Management of the Patient With Syncope
Kapoor
JAMA 1992;268:2553-2560.
ABSTRACT  

Syncope: Current Diagnostic Evaluation and Management
Manolis et al.
ANN INTERN MED 1990;112:850-863.
ABSTRACT